Véronique Mathieu

6.7k total citations
134 papers, 5.4k citations indexed

About

Véronique Mathieu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Véronique Mathieu has authored 134 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 45 papers in Organic Chemistry and 34 papers in Pharmacology. Recurrent topics in Véronique Mathieu's work include Microbial Natural Products and Biosynthesis (24 papers), Chemical synthesis and alkaloids (24 papers) and Alkaloids: synthesis and pharmacology (18 papers). Véronique Mathieu is often cited by papers focused on Microbial Natural Products and Biosynthesis (24 papers), Chemical synthesis and alkaloids (24 papers) and Alkaloids: synthesis and pharmacology (18 papers). Véronique Mathieu collaborates with scholars based in Belgium, Italy and United States. Véronique Mathieu's co-authors include Róbert Kiss, Florence Lefranc, Alexander Kornienko, Antonio Evidente, Alessio Cimmino, Anna Andolfi, Nathalie Wauthoz, Tatjana Mijatovic, Gwendoline Van Goietsenoven and Christine Decaestecker and has published in prestigious journals such as Biomaterials, Cancer Research and Scientific Reports.

In The Last Decade

Véronique Mathieu

133 papers receiving 5.3k citations

Peers

Countries citing papers authored by Véronique Mathieu

Since Specialization

Citations

This map shows the geographic impact of Véronique Mathieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Mathieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Mathieu more than expected).

Fields of papers citing papers by Véronique Mathieu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Mathieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Mathieu. The network helps show where Véronique Mathieu may publish in the future.

Co-authorship network of co-authors of Véronique Mathieu

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Mathieu. A scholar is included among the top collaborators of Véronique Mathieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Mathieu. Véronique Mathieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activity 2022 ·Inorganic Chemistry Frontiers ·(unknown), (unknown), (unknown), (unknown), (unknown), Marilin Koch, Michal O. Nowicki, Véronique Mathieu, Justin R. Pritchard, Samuel G. Awuah, Sean Lawler, F. Meyer, François Dufrasne, Gilles Berger	5
2	In Vitro Antioxidant and Anticancer Properties of Various E. senegalensis Extracts 2022 ·Molecules ·(unknown), Cédric Delporte, (unknown), Moussa Ouédraogo, Pierre Van Antwerpen, Innocent Pierre Guissou, Rasmané Semdé, Véronique Mathieu	10
3	Deciphering the chemical instability of sphaeropsidin A under physiological conditions – degradation studies and structural elucidation of the major metabolite 2020 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), Rémi Rosière, Karim Amighi, Lukas Oberer, Kirk R. Gustafson, Dongdong Wang, Antonio Evidente, Lucia Maddau, Marco Masi, André de Villiers, Ivan R. Green, Walter Berger, Alexander Kornienko, Véronique Mathieu, Willem A. L. van Otterlo	1
4	Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure 2017 ·Journal of Medicinal Chemistry ·Jalal Soubhye, (unknown), (unknown), Martine Prévost, Michel Gelbcke, (unknown), Paul G. Furtmüller, Christian Obinger, Jörg Flemmig, (unknown), F. Meyer, Alexandre Fontaine Rousseau, Jean Nève, Véronique Mathieu, Karim Zouaoui Boudjeltia, François Dufrasne, Pierre Van Antwerpen	31
5	Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy 2017 ·Scientific Reports ·Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, Rémi Rosière, Abhishek D. Garg, Patrizia Agostinis, Véronique Mathieu, Róbert Kiss, Florence Lefranc, Louis Boon, Jochen Belmans, Stefaan Van Gool, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer	114
6	A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis 2017 ·European Journal of Pharmacology ·(unknown), Jennifer Chu, (unknown), Róbert Kiss, Guy Vandenbussche, Bernard Masereel, Johan Wouters, Alexander Kornienko, Jerry Pelletier, Véronique Mathieu	52
7	Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration 2016 ·Journal of Controlled Release ·Matthias Van Woensel, Nathalie Wauthoz, Rémi Rosière, Véronique Mathieu, Róbert Kiss, Florence Lefranc, Brecht Steelant, Ellen Dilissen, Stefaan W. Van Gool, Thomas Mathivet, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer	133
8	Infrared spectra of primary melanomas can predict response to chemotherapy: The example of dacarbazine 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Noémie Wald, (unknown), Ludovic Martin, Véronique Mathieu, Erik Goormaghtigh	16
9	Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells 2015 ·Bioorganic & Medicinal Chemistry Letters ·Serena Fiorito, Salvatore Genovese, Vito Alessandro Taddeo, Véronique Mathieu, Róbert Kiss, Francesco Epifano	16
10	Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase 2015 ·Cellular and Molecular Life Sciences ·Véronique Mathieu, Aurélie Chantôme, Florence Lefranc, Alessio Cimmino, Walter Miklos, Verena Paulitschke, Thomas Mohr, Lucia Maddau, Alexander Kornienko, Walter Berger, Christophe Vandier, Antonio Evidente, Eric Delpire, Róbert Kiss	36
11	4-Bromo-2-(piperidin-1-yl)thiazol-5-yl-phenyl methanone (12b) inhibits Na+/K+-ATPase and Ras oncogene activity in cancer cells 2013 ·European Journal of Medicinal Chemistry ·Florence Lefranc, (unknown), Patrícia Burth, Véronique Mathieu, (unknown), Mauro Velho de Castro Faria, Caroline Noyon, (unknown), (unknown), Céline Bruyère, Cassiano Felippe Gonçalves-de-Albuquerque, Pierre Van Antwerpen, Bernard Rogister, Stéphanie Hesse, Gilbert Kirsch, Róbert Kiss	16
12	Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives 2013 ·Bioorganic & Medicinal Chemistry Letters ·Serena Fiorito, Francesco Epifano, Céline Bruyère, Véronique Mathieu, Róbert Kiss, Salvatore Genovese	42
13	Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca²⁺release 2011 ·Journal of Cellular and Molecular Medicine ·Delphine Lamoral‐Theys, Nathalie Wauthoz, Petra Heffeter, Véronique Mathieu, Ute Jungwirth, Florence Lefranc, Jean Nève, Jacques Dubois, François Dufrasne, Karim Amighi, Walter Berger, Philippe Gailly, Róbert Kiss	13
14	Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity 2010 ·Cancer Research ·Victor L. Thijssen, Batya Barkan, Hiroki Shoji, Ingrid M. Ariës, Véronique Mathieu, Louise Deltour, Tilman M. Hackeng, Róbert Kiss, Yoel Kloog, Françoise Poirier, Arjan W. Griffioen	193
15	Galectins and Gliomas 2009 ·Brain Pathology ·Marie Le Mercier, Shannon P. Fortin Ensign, Véronique Mathieu, Róbert Kiss, Florence Lefranc	89
16	Amaryllidaceae Isocarbostyril Alkaloids and Their Derivatives as Promising Antitumor Agents 2008 ·Translational Oncology ·Laurent Ingrassia, Florence Lefranc, Véronique Mathieu, Francis Darro, Róbert Kiss	81
17	UNBS4209: A bilactosylated steroid with anti-galectin-1 activity 2007 ·Cancer Research ·Laurent Ingrassia, Véronique Mathieu, Véronique Mégalizzi, Florence Lefranc, Francis Darro, Róbert Kiss	1
18	UNBS1450-mediated cMyc down-regulation and nucleolar targeting in carcinoma cells through over-expressed sodium pump alpha-1 subunit. 2007 ·Molecular Cancer Therapeutics ·Tatjana Mijatovic, Nancy De Nève, Véronique Mathieu, Eric Van Quaquebeke, Francis Darro, Róbert Kiss	1
19	Neurotensin is a Versatile Modulator of In Vitro Human Pancreatic Ductal Adenocarcinoma Cell (PDAC) Migration 2007 ·Analytical Cellular Pathology ·Tatjana Mijatovic, Philippe Gailly, Véronique Mathieu, Nancy De Nève, Paul Yeaton, Róbert Kiss, Christine Decaestecker	35
20	Anti-Galectin Compounds as Potential Anti-Cancer Drugs 2006 ·Current Medicinal Chemistry ·Laurent Ingrassia, Isabelle Camby, Florence Lefranc, Véronique Mathieu, (unknown), Francis Darro, Róbert Kiss	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact